These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 8441174

  • 1. Plasminogen activators and plasminogen activator inhibitors in synovial fluid. Difference between inflammatory joint disorders and osteoarthritis.
    Saxne T, Lecander I, Geborek P.
    J Rheumatol; 1993 Jan; 20(1):91-6. PubMed ID: 8441174
    [Abstract] [Full Text] [Related]

  • 2. Difference in expression of the plasminogen activation system in synovial tissue of patients with rheumatoid arthritis and osteoarthritis.
    Ronday HK, Smits HH, Van Muijen GN, Pruszczynski MS, Dolhain RJ, Van Langelaan EJ, Breedveld FC, Verheijen JH.
    Br J Rheumatol; 1996 May; 35(5):416-23. PubMed ID: 8646430
    [Abstract] [Full Text] [Related]

  • 3. Effects of tiaprofenic acid on plasminogen activators and inhibitors in human OA and RA synovium.
    Pelletier JP, McCollum R, Cloutier JM, Martel-Pelletier J.
    Br J Rheumatol; 1992 May; 31 Suppl 1():19-26. PubMed ID: 1555050
    [Abstract] [Full Text] [Related]

  • 4. Plasminogen activators and their inhibitors in synovial fluids from normal, osteoarthritis, and rheumatoid arthritis knees.
    Belcher C, Fawthrop F, Bunning R, Doherty M.
    Ann Rheum Dis; 1996 Apr; 55(4):230-6. PubMed ID: 8733439
    [Abstract] [Full Text] [Related]

  • 5. Depression of tissue-type plasminogen activator and enhancement of urokinase-type plasminogen activator as an expression of local inflammation.
    Brommer EJ, Dooijewaard G, Dijkmans BA, Breedveld FC.
    Thromb Haemost; 1992 Aug 03; 68(2):180-4. PubMed ID: 1412164
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Control of the chondrocyte fibrinolytic balance by the drug piroxicam: relevance to the osteoarthritic process.
    Fibbi G, Serni U, Matucci A, Mannoni A, Pucci M, Anichini E, Del Rosso M.
    J Rheumatol; 1994 Dec 03; 21(12):2322-8. PubMed ID: 7699636
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Plasmin, plasminogen activators and inhibitor in human osteoarthritic cartilage.
    Martel-Pelletier J, Faure MP, McCollum R, Mineau F, Cloutier JM, Pelletier JP.
    J Rheumatol; 1991 Dec 03; 18(12):1863-71. PubMed ID: 1724464
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.